Genomics company 23andMe filed for bankruptcy, raising concerns among millions of users whose data may be sold. The case has sparked debates on whether blockchain could enhance the protection of genetic information.
23andMe Bankruptcy and Its Consequences
23andMe, known for its genetic testing, announced bankruptcy on March 23. Experts express concerns over user data protection, as sales may put their genomic information at risk. The court approved the sale of data, prompting criticism from privacy advocates. Many users are now seeking ways to delete their data from the system.
23andMe's Privacy History
23andMe has faced repeated criticisms over data privacy. Its processes for collecting and selling client data have always aroused concern among users. Despite claims of transparent data sharing policies, 23andMe has faced data breaches and cyberattacks, notably in 2023.
Blockchain Possibilities for Genomic Data
23andMe's bankruptcy has attracted attention to the idea of storing genetic data on the blockchain. This technology offers potentially more secure and decentralized solutions, enhancing protection for confidential information. However, some experts note challenges related to storage costs and potential vulnerabilities.
The 23andMe situation has highlighted the need for new approaches to storing and protecting genetic information. As debates about blockchain as an alternative continue, users must make informed decisions about safeguarding their data.
